Nectar Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has informed the stock exchanges that its unaudited financial results for the quarter ended June 30, 2025 have been published in newspapers as required under SEBI Listing Regulations. The results appeared in Business Standard (English, all editions) and Desh Sewak (Punjabi) on August 15, 2025. This is a routine compliance filing confirming newspaper publication of results that were already approved and disclosed earlier. The letter is signed by Sanjaymohan Singh Rawat, Company Secretary & Compliance Officer.
This is a standard regulatory compliance disclosure and carries no new material information for shareholders. No impact on stock price is expected, as it merely confirms the newspaper publication of already-announced Q1FY26 results.